• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    71 Biggest Movers From Yesterday

    4/27/22 4:27:24 AM ET
    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADXN alert in real time by email

    Gainers

    • Evoke Pharma, Inc. (NASDAQ:EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (metoclopramide) nasal spray to relieve symptoms associated with acute and recurrent diabetic gastroparesis in adults.
    • Nutex Health, Inc. (NASDAQ:NUTX) gained 73.8% to close at $7.68 on above-average volume despite no company-specific news.
    • Cyngn Inc. (NASDAQ:CYN) jumped 52.1% to close at $3.68 on above-average volume despite no company-specific news to justify the price action.
    • Forge Global Holdings, Inc. (NYSE:FRGE) gained 40.4% to close at $18.46 on above-average volume.
    • GeoVax Labs, Inc. (NASDAQ:GOVX) jumped 29.8% to settle at $1.11. The U.S. Patent and Trademark Office issued Patent No. 11,311,612 covering GeoVax Labs modified vaccinia Ankara (MVA) vector expressing certain antigens from the malaria parasite.
    • Jiuzi Holdings, Inc. (NASDAQ:JZXN) gained 27.3% to close at $1.68 after the company announced it entered into an equity acquisition agreement to acquire an automobile sales serviceshop operator under top china automaker Geely Auto's premium electronic vehicle brand Geometry.
    • Avadel Pharmaceuticals plc. (NASDAQ:AVDL) shares climbed 25.9% to close at $5.30 on Tuesday. Shares closed down 36% on Monday, seemingly on no news. Avadel issued a press release Tuesday morning that highlighted the company was not aware of any new information related to the company's FT218 New Drug Application that would have caused the stock to move.
    • Addex Therapeutics Ltd (NASDAQ:ADXN) gained 23.8% to close at $5.35.
    • Arch Resources, Inc. (NYSE:ARCH) climbed 21% to close at $158.83 after the company reported better-than-expected Q1 sales results.
    • Lizhi Inc. (NASDAQ:LIZI) gained 20% to close at $1.32. LIZHI recently said it is collaborating with the in-car Xiaomi Quick App Platform to integrate LIZHI’s in-car audio product into Leapmotor vehicles’ operating system.
    • Q&K International Group Limited (NASDAQ:QK) shares climbed 18.6% to close at $1.18 after dropping around 5% on Monday.
    • Agile Therapeutics, Inc. (NASDAQ:AGRX) fell 17.5% to close at $0.1119 after declining 4% on Monday.
    • Magnachip Semiconductor Corporation (NYSE:MX) shares climbed 16.5% to close at $17.51 following a Korea Economic Daily report titled "Korea's LX Group seeks to acquire Magnachip Semiconductor."
    • Cosmos Holdings Inc. (NASDAQ:COSM) jumped 16.5% to close at $1.06.
    • Eargo, Inc. (NASDAQ:EAR) surged 16.3% to settle at $4.07.
    • Mastech Digital, Inc. (NYSE:MHH) rose 15% to close at $20.99.
    • Digital World Acquisition Corp. (NASDAQ:DWAC) jumped 14.3% to close at $40.80.
    • Travelzoo (NASDAQ:TZOO) gained 14.2% to close at $7.18 after the company reported better-than-expected Q1 EPS and sales results.
    • Sky Harbour Group Corporation (NYSE:SKYH) rose 13.9% to close at $10.58 after jumping 16% on Monday.
    • EuroDry Ltd. (NASDAQ:EDRY) gained 11.6% to settle at $35.96. EuroDry recently announced plans to acquire M/V Santa Cruz Bulker for $15.75 million.
    • The Sherwin-Williams Company (NYSE:SHW) climbed 9.4% to close at $271.37 after the company reported better-than-expected Q1 EPS and sales results.
    • Morphic Holding, Inc. (NASDAQ:MORF) rose 7% to close at $31.87.
    • PHX Minerals Inc. (NYSE:PHX) jumped 6.1% to close at $3.65.
    • Waste Management, Inc. (NYSE:WM) gained 5.3% to close at $164.15 after the company reported better-than-expected Q1 EPS and sales results.
    • Whirlpool Corporation (NYSE:WHR) jumped 4.6% to close at $187.16 after the company reported Q1 financial results and raised its buyback program by $2 billion.
    • Venator Materials PLC (NYSE:VNTR) rose 4.5% to close at $1.86 after the company announced the receipt of $85 million in cash from Tronox pursuant to its settlement agreement with Tronox.


    Losers

    • Protagonist Therapeutics, Inc. (NASDAQ:PTGX) shares tumbled 50% to close at $9.41 on Tuesday after the company announced topline results from the Phase 2 IDEAL study of PN-943 in moderate-to-severe ulcerative colitis (UC) patients.
    • Enjoy Technology, Inc. (NASDAQ:ENJY) declined 30% to close at $1.45 on above-average volume.
    • LogicBio Therapeutics, Inc. (NASDAQ:LOGC) fell 25.7% to close at $0.4010.
    • Theseus Pharmaceuticals, Inc. (NASDAQ:THRX) dipped 23.8% to settle at $8.26 on below-average volume.
    • ERYTECH Pharma S.A. (NASDAQ:ERYP) shares fell 23.2% to settle at $1.29. Erytech Pharma shares jumped around 38% on Monday after the company announced it has sold its U.S. cell therapy manufacturing facility to Catalent For $44.5 million.
    • Winc, Inc. (NYSE:WBEV) fell 22.5% to close at $2.97.
    • Vallon Pharmaceuticals, Inc. (NASDAQ:VLON) dropped 20.1% to close at $1.55.
    • PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS) fell 19.4% to settle at $1.12 on below-average volume.
    • Heidrick & Struggles International, Inc. (NASDAQ:HSII) dropped 19% to close at $32.11 following Q1 earnings.
    • Ventyx Biosciences, Inc. (NASDAQ:VTYX) fell 18.9% to close at $13.30.
    • Candel Therapeutics, Inc. (NASDAQ:CADL) fell 17.8% to close at $3.97.
    • Molecular Partners AG (NASDAQ:MOLN) fell 17.8% to close at $13.89. Molecular Partners said Emergency Use Authorization for Ensovibep, which is filed and in review with U.S. FDA, may require additional clinical data to be authorized.
    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) fell 17.7% to close at $3.30. Sunshine Biopharma recently reported it filed a provisional patent application in the US covering the recently communicated mRNA molecules found in pre-clinical trials to be effective at destroying cancer cells grown in culture.
    • Agile Therapeutics, Inc. (NASDAQ:AGRX) fell 17.5% to close at $0.1119. Agile Therapeutics announced a 1-for-40 reverse stock split.
    • Baosheng Media Group Holdings Limited (NASDAQ:BAOS) dropped 17% to close at $0.6550.
    • Swvl Holdings Corp. (NASDAQ:SWVL) dipped 17% to close at $6.37.
    • NexImmune, Inc. (NASDAQ:NEXI) dipped 16.8% to close at $2.18. NexImmune reported a preclinical research collaboration with Columbia University Irving Medical Center's Herbert Irving Comprehensive Cancer Center.
    • Moving iMage Technologies, Inc. (NASDAQ:MITQ) dropped 16.7% to settle at $1.30. Moving iMage Technologies and SNDBX recently announced a strategic partnership to bring the full theatre experience to the gaming and e-Sports market.
    • Zymergen Inc. (NASDAQ:ZY) fell 16.6% to close at $1.71.
    • Inotiv, Inc. (NASDAQ:NOTV) dropped 16.4% to settle at $17.28. Inotiv recently announced acquisition of Histion.
    • Avalo Therapeutics, Inc. (NASDAQ:AVTX) declined 16.3% to close at $0.4938.
    • Senmiao Technology Limited (NASDAQ:AIHS) fell 16.3% to close at $1.03.
    • Global Internet of People, Inc. (NASDAQ:SDH) dipped 16% to close at $1.68.
    • Leju Holdings Limited (NYSE:LEJU) fell 16% to close at $0.3611.
    • ION Geophysical Corporation (NYSE:IO) shares fell 15.7% to close at $0.58 after jumping 46% on Monday.
    • Gossamer Bio, Inc. (NASDAQ:GOSS) dipped 15.5% to close at $7.67. Gossamer Bio recently announced topline results from the Phase 2 SHIFT-UC study in ulcerative colitis did not meet primary or secondary endpoints at week 12.
    • Longeveron Inc. (NASDAQ:LGVN) fell 15.5% to close at $10.41.
    • NuCana plc (NASDAQ:NCNA) fell 15.4% to close at $0.7177.
    • IM Cannabis Corp. (NASDAQ:IMCC) dipped 15.2% to settle at $1.12.
    • IsoPlexis Corporation (NASDAQ:ISO) fell 15% to close at $1.93.
    • Cenntro Electric Group Limited (NASDAQ:CENN) fell 14.9% to close at $1.60 after reporting FY21 results.
    • ATIF Holdings Limited (NASDAQ:ATIF) dipped 14.8% to close at $2.82.
    • Nuvve Holding Corp. (NASDAQ:NVVE) declined 13% to close at $5.78. Nuvve Holding filed for mixed shelf of up to $100 million.
    • JE Cleantech Holdings Limited (NASDAQ:JCSE) fell 12.9% to close at $16.21. The company, last week, priced its IPO at $4 per share.
    • Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) dropped 12.9% to close at $3.10.
    • iHuman Inc. (NYSE:IH) fell 12.5% to settle at $2.59.
    • Tesla, Inc. (NASDAQ:TSLA) dipped 12.2% to close at $876.42.
    • General Electric Company (NYSE:GE) dipped 10.3% to close at $80.59 as the company reported first-quarter FY22 adjusted revenue of $16.3 billion flat year-over-year and organic revenues of $16.43 billion, up 1% Y/Y.
    • Nkarta, Inc. (NASDAQ:NKTX) dropped 10.3% to close at $16.79 as the company reported pricing of upsized public offering of common stock.
    • Universal Health Services, Inc. (NYSE:UHS) fell 9.7% to close at $125.32 after the company reported worse-than-expected Q1 EPS results.
    • TrueBlue, Inc. (NYSE:TBI) dipped 8.5% to close at $26.48 following Q1 results.
    • Polaris Inc. (NYSE:PII) fell 7.8% to settle at $98.49 after the company reported worse-than-expected Q1 EPS and sales results.
    • HSBC Holdings plc (NYSE:HSBC) fell 7.8% to close at $29.84 after the company reported a 28% drop in pre-tax profits for the first three months of 2022.
    • Helix Energy Solutions Group, Inc. (NYSE:HLX) fell 7.2% to close at $4.26 following Q1 results.
    • NextDecade Corporation (NASDAQ:NEXT) fell 6.6% to close at $5.66. Stifel downgraded NextDecade from Hold to Sell and raised the price target from $2 to $4.
    Get the next $ADXN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADXN
    $AGRX
    $AIHS
    $ARCH

    CompanyDatePrice TargetRatingAnalyst
    Gossamer Bio Inc.
    $GOSS
    2/24/2026$1.00Outperform → Neutral
    Wedbush
    Gossamer Bio Inc.
    $GOSS
    2/24/2026$0.30Overweight → Equal Weight
    Barclays
    Gossamer Bio Inc.
    $GOSS
    2/24/2026$1.00Outperform → Market Perform
    Leerink Partners
    GE Aerospace
    $GE
    2/20/2026$425.00Overweight
    Morgan Stanley
    GeoVax Labs Inc.
    $GOVX
    2/19/2026Buy → Hold
    D. Boral Capital
    Tesla Inc.
    $TSLA
    2/12/2026$550.00Buy
    Tigress Financial
    EuroDry Ltd.
    $EDRY
    2/12/2026$23.50Market Perform → Outperform
    Noble Capital Markets
    NextDecade Corporation
    $NEXT
    2/6/2026$7.00Overweight
    CapitalOne
    More analyst ratings

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    SEC Filings

    View All

    SEC Form 8-A12B filed by Whirlpool Corporation

    8-A12B - WHIRLPOOL CORP /DE/ (0000106640) (Filer)

    2/27/26 5:01:44 PM ET
    $WHR
    Consumer Electronics/Appliances
    Consumer Discretionary

    Whirlpool Corporation filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement

    8-K - WHIRLPOOL CORP /DE/ (0000106640) (Filer)

    2/27/26 4:31:21 PM ET
    $WHR
    Consumer Electronics/Appliances
    Consumer Discretionary

    SEC Form 6-K filed by HSBC Holdings plc.

    6-K - HSBC HOLDINGS PLC (0001089113) (Filer)

    2/27/26 12:49:28 PM ET
    $HSBC
    Savings Institutions
    Finance

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bobbili Raja bought $12,311,558 worth of shares (1,758,794 units at $7.00) (SEC Form 4)

    4 - ContextLogic Holdings Inc. (0002064307) (Issuer)

    2/26/26 8:42:27 PM ET
    $LOGC
    Catalog/Specialty Distribution
    Consumer Discretionary

    Large owner Abrams Capital Management, L.P. bought $12,311,558 worth of shares (1,758,794 units at $7.00) (SEC Form 4)

    4 - ContextLogic Holdings Inc. (0002064307) (Issuer)

    2/26/26 8:37:36 PM ET
    $LOGC
    Catalog/Specialty Distribution
    Consumer Discretionary

    Director Abrams David C bought $12,311,558 worth of shares (1,758,794 units at $7.00) (SEC Form 4)

    4 - ContextLogic Holdings Inc. (0002064307) (Issuer)

    2/26/26 8:36:32 PM ET
    $LOGC
    Catalog/Specialty Distribution
    Consumer Discretionary

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Gossamer Bio downgraded by Wedbush with a new price target

    Wedbush downgraded Gossamer Bio from Outperform to Neutral and set a new price target of $1.00

    2/24/26 8:01:18 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Gossamer Bio downgraded by Barclays with a new price target

    Barclays downgraded Gossamer Bio from Overweight to Equal Weight and set a new price target of $0.30

    2/24/26 7:42:57 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Gossamer Bio downgraded by Leerink Partners with a new price target

    Leerink Partners downgraded Gossamer Bio from Outperform to Market Perform and set a new price target of $1.00

    2/24/26 7:42:57 AM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nkarta to Participate in March Investor Conferences

    SOUTH SAN FRANCISCO, Calif., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (NASDAQ:NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today announced its participation in the following investor conferences: March 2, 2026TD Cowen 46th Annual Health Care ConferenceBoston, MA9:10 a.m. EST – fireside chatMarch 10, 2026Leerink Global Healthcare ConferenceMiami, FL10:40 a.m. EDT – fireside chatA simultaneous webcast of both events will be available on the Investors section of Nkarta's website, and a replay will be archived on the website for approximately 90 days. About NkartaNkarta is a clinical-stage biote

    2/27/26 8:00:00 AM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ContextLogic Completes $907.5 Million Acquisition of US Salt, Marking Transformation into Business Ownership Platform

    OAKLAND, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- ContextLogic Holdings Inc. (OTCQB:LOGC) ("ContextLogic," the "Company," "we" or "our") today announced the successful completion of its acquisition of US Salt Parent Holdings, LLC and its subsidiaries (collectively, "US Salt") from private equity funds managed by Emerald Lake Capital Management ("Emerald Lake") in a transaction that valued US Salt at an enterprise value of approximately $907.5 million (the "Transaction"). The closing of this Transaction marks a transformational milestone for ContextLogic, completing its evolution from an e-commerce company into a distinctive business ownership platform focused on owning niche, competiti

    2/26/26 4:45:00 PM ET
    $LOGC
    Catalog/Specialty Distribution
    Consumer Discretionary

    Whirlpool Corporation to Present at Raymond James' 47th Annual Institutional Investors Conference

    BENTON HARBOR, Mich., Feb. 26, 2026 /PRNewswire/ -- Whirlpool Corporation (NYSE:WHR) announced today that it will participate in the Raymond James 47th Annual Institutional Investors Conference on March 2nd at 8:05 a.m. ET at the JW Marriott Grande Lakes in Orlando, Florida. Presenting for Whirlpool Corporation will be Roxanne Warner, Executive Vice President and Chief Financial Officer. The Company invites investors and the general public to view the webcast of the presentation, which will be available on the events & presentations page of the Company's Investor Relations websi

    2/26/26 4:05:00 PM ET
    $WHR
    Consumer Electronics/Appliances
    Consumer Discretionary

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Wilson-Thompson Kathleen exercised 40,000 shares at a strike of $14.99 and sold $10,692,814 worth of shares (25,731 units at $415.56), increasing direct ownership by 264% to 19,669 units (SEC Form 4)

    4 - Tesla, Inc. (0001318605) (Issuer)

    2/27/26 7:00:21 PM ET
    $TSLA
    Auto Manufacturing
    Industrials

    SEC Form 4 filed by EVP & CFO Staffeldt Erik

    4 - HELIX ENERGY SOLUTIONS GROUP INC (0000866829) (Issuer)

    2/27/26 4:05:25 PM ET
    $HLX
    Oilfield Services/Equipment
    Energy

    SEC Form 4 filed by PRESIDENT & CEO Kratz Owen E

    4 - HELIX ENERGY SOLUTIONS GROUP INC (0000866829) (Issuer)

    2/27/26 4:05:19 PM ET
    $HLX
    Oilfield Services/Equipment
    Energy

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for GIMOTI

    Submission status for EVOKE PHARMA INC's drug GIMOTI (SUPPL-1) with active ingredient METOCLOPRAMIDE HYDROCHLORIDE has changed to 'Approval' on 01/14/2021. Application Category: NDA, Application Number: 209388, Application Classification: Labeling

    1/15/21 5:10:35 AM ET
    $EVOK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Financials

    Live finance-specific insights

    View All

    Nutex Health Schedules 2025 Fourth Quarter and Year-End Financial Results and Earnings Conference Call

    HOUSTON, Feb. 25, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Annual Report on Form 10‑K for the fiscal year ended December 31, 2025, on Thursday, March 5, 2026, after the market close. The Company will also issue a corresponding press release summarizing financial results on the same day. Nutex Health will host its earnings conference call on Friday, March 6, 2026, at 9:30 a.m. CT to discuss the Company's financial performance and

    2/25/26 5:29:00 PM ET
    $NUTX
    Real Estate

    UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND TWELVE-MONTH PERIODS ENDED DECEMBER 31, 2025 AND OPERATING RESULTS FORECAST FOR THE FULL YEAR OF 2026

    Consolidated Results of Operations, As Reported and As Adjusted  – Three-month periods ended December 31, 2025 and 2024:KING OF PRUSSIA, Pa., Feb. 25, 2026 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $445.9 million, or $7.06 per diluted share, during the fourth quarter of 2025, as compared to $332.4 million, or $4.96 per diluted share, during the fourth quarter of 2024.  Net revenues increased by 9.1% to $4.486 billion during the fourth quarter of 2025, as compared to $4.114 billion during the fourth quarter of 2024. As reflected on the Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"),

    2/25/26 4:16:00 PM ET
    $UHS
    $UHT
    Hospital/Nursing Management
    Health Care
    Real Estate Investment Trusts
    Real Estate

    Helix Reports Fourth Quarter and Full Year 2025 Results

    Helix Energy Solutions Group, Inc. ("Helix") (NYSE:HLX) reported net income of $8.3 million, or $0.06 per diluted share, for the fourth quarter 2025 compared to net income of $22.1 million, or $0.15 per diluted share, for the third quarter 2025 and net income of $20.1 million, or $0.13 per diluted share, for the fourth quarter 2024. Net income during the fourth quarter 2025 included a non-cash impairment charge for certain of our oil and gas properties of approximately $18.1 million (pre-tax). Helix reported Adjusted EBITDA1 of $73.9 million for the fourth quarter 2025 compared to $103.7 million for the third quarter 2025 and $71.6 million for the fourth quarter 2024. For the full year 20

    2/23/26 6:15:00 PM ET
    $HLX
    Oilfield Services/Equipment
    Energy

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Leadership Updates

    Live Leadership Updates

    View All

    TrueBlue Appoints Mike Kruszewski to President of PeopleReady On-Demand

    TrueBlue (NYSE:TBI), a leading provider of specialized workforce solutions, today announced that Mike Kruszewski has been appointed President of PeopleReady On-Demand. In his expanded role, Mr. Kruszewski will lead the PeopleReady On-Demand business, with responsibility for strategy, sales, and operational performance. Mr. Kruszewski joined PeopleReady in November of 2025 as Head of Sales and has played a key role in advancing the Company's territory-based operating model, strengthening commercial execution, and expanding sales capacity in priority markets. "Since joining, Mike has sharpened our sales strategy, clarified success metrics, and aligned our teams to execute within our territo

    2/26/26 8:00:00 AM ET
    $TBI
    Professional Services
    Consumer Discretionary

    Cyngn Adds Former Lyft Exec, Ran Makavy, to Board

    Mr. Makavy led growth at Lyft and later ran its core platform through the 2019 IPO. He also founded Snaptu, which was acquired by Facebook in 2011.MOUNTAIN VIEW, Calif., Feb. 25, 2026 /PRNewswire/ -- Cyngn (NASDAQ:CYN) today announced the appointment of Ran Makavy to its Board of Directors. He brings senior growth and platform leadership experience from Lyft and Facebook, where he helped scale large technology businesses through high-growth phases. At Lyft, Makavy built the growth team which was responsible for getting more drivers and riders to use Lyft and getting them to use

    2/25/26 7:05:00 AM ET
    $CYN
    EDP Services
    Technology

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Candel Therapeutics Inc.

    SC 13G - Candel Therapeutics, Inc. (0001841387) (Subject)

    12/17/24 12:30:40 PM ET
    $CADL
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Nkarta Inc.

    SC 13G - Nkarta, Inc. (0001787400) (Subject)

    12/13/24 5:02:47 PM ET
    $NKTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Ventyx Biosciences Inc.

    SC 13G/A - Ventyx Biosciences, Inc. (0001851194) (Subject)

    11/14/24 7:54:08 PM ET
    $VTYX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADXN
    $AGRX
    $AIHS
    $ARCH
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Gossamer Bio Inc. on Jun 21

    Gossamer Bio Inc. recently witnessed an insider purchase by COO/CFO Bryan Giraudo, who acquired $59,110 worth of shares consisting of 100,000 units at $0.59 per share. Insider purchases like this can provide valuable insights for investors, indicating confidence from individuals within the company about its future prospects. Examining previous insider transactions, on 2024-03-19, insiders Peterson Caryn and Aranda Richard each sold $5,343 worth of shares at $1.33, leading to a decrease in their direct ownership percentages. Similarly, on 2024-03-28, Hasnain Faheem, Giraudo Bryan, and Christian Waage sold shares worth $26,773, $7,431, and $7,430, respectively, impacting their direct ownershi

    6/21/24 3:17:31 PM ET
    $GOSS
    Biotechnology: Pharmaceutical Preparations
    Health Care